STEPHANIE SHIBATA: Open Payments
NPI 1366863953 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$318 in 16 payments from 7 companies in 2025. Trend: 2023 $936 · 2024 $687 · 2025 $318
Food & beverage: $318
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 5 | $92 |
| Insmed, Inc. | 3 | $62 |
| ABBVIE INC. | 2 | $43 |
| Paratek Pharmaceuticals, Inc. | 2 | $39 |
| Gilead Sciences, Inc. | 2 | $36 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| Napo Pharmaceuticals Inc | 1 | $16 |
Products named: Arikayce, DALVANCE, NUZYRA, CABENUVA, DOVATO, PIFELTRO, APRETUDE, Mytesi.
Industry payments across NV — which companies pay providers there.
